NDC 67046-0686-03 - Lisinopril and Hydrochlorothiazide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 67046-0686
- Requested NDC
- 67046-0686-03
- Package NDCs from labels
- 67046-0686-3, 67046-0686-03
- Manufacturer
- Coupler LLC | LUPIN LIMITED
- Effective date
- 2026-11-02
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Lisinopril and Hydrochlorothiazide - Coupler LLC | LUPIN LIMITED | Coupler LLC | LUPIN LIMITED | 2026-11-02 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | f20fd735-30c7-4f89-8ceb-b6186646eea6 | 2026-10-22 | Warnings, Adverse reactions | 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Preferred Pharmaceuticals Inc. | 1fff8245-2b65-4ab1-aaa2-6bbbc6ac5fe8 | 2026-10-19 | Boxed warning, Adverse reactions | 0J48LPH2TH |
| olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | OLMESARTAN MEDOXOMIL / AMLODIPINE BESYLATE / HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 57ffeef7-bfa8-4f92-aadc-23cd00022607 | 2026-10-19 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Preferred Pharmaceuticals Inc. | 5fc69fbf-c2d2-41ef-99bb-62a76ef74db2 | 2026-10-19 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Telmisartan and Hydrochlorothiazide | TELMISARTAN AND HYDROCHLOROTHIAZIDE | Aurobindo Pharma Limited | 681dfb5c-fc5c-427e-81f6-4b4e934978a2 | 2026-10-16 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| LISINOPRIL | LISINOPRIL | PD-Rx Pharmaceuticals, Inc. | 705582ed-da8c-418f-8bb2-fc0b74ed0a88 | 2026-10-15 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR |
| LISINOPRIL | LISINOPRIL | St. Mary's Medical Park Pharmacy | 5eff766f-82e2-4cd6-e053-2a91aa0a4782 | 2026-10-15 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | REMEDYREPACK INC. | 3bea11a3-eb07-46b2-9b91-f8a48a2f3b7e | 2026-10-12 | Boxed warning, Warnings, Adverse reactions | 197886 E7199S1YWR 0J48LPH2TH |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 31a3d1cb-0f52-4818-965d-7584374bb23e | 2026-10-12 | Warnings, Adverse reactions | 0J48LPH2TH |
| LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Granules Pharmaceuticals Inc. | b4168479-09ec-402c-89cc-456bc8485017 | 2026-10-08 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Advagen Pharma Ltd | f4b10352-a923-4713-9d33-8f3636941b2e | 2026-10-08 | Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | NuCare Pharmaceuticals,Inc. | 8bc8d5e2-a974-64ed-e053-2a95a90a8340 | 2026-10-08 | Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril | LISINOPRIL | BluePoint Laboratories | 34ebeea1-6812-4697-84c4-b2ae4f39e55f | 2026-10-07 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR |
| LISINOPRIL | LISINOPRIL | St. Mary's Medical Park Pharmacy | 6062fd98-7663-f4b5-e053-2a91aa0acbc3 | 2026-10-01 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | St. Mary's Medical Park Pharmacy | 00b266d9-ac4a-e931-e063-6294a90a6a0b | 2026-10-01 | Boxed warning, Warnings, Adverse reactions | 197885 E7199S1YWR 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Westminster Pharmaceuticals, LLC | 0fc94bc2-fa38-439a-a609-1b4130cdacb1 | 2026-09-29 | Warnings, Adverse reactions | 0J48LPH2TH |
| OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | Ascend Laboratories, LLC | 798fee33-51ad-45d0-82f3-09289304139f | 2026-09-24 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Preferred Pharmaceuticals Inc. | b9b85048-5776-455f-bea6-6ab818cb8144 | 2026-09-24 | Warnings, Adverse reactions | 0J48LPH2TH |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 2dd7c2a4-d335-4c6f-b1e6-b0ae6eebab84 | 2026-09-23 | Warnings, Adverse reactions | 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Zydus Lifesciences Limited | e92f1118-8eaf-4fa8-b167-1447550af1ab | 2026-09-18 | Boxed warning, Adverse reactions | 0J48LPH2TH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.